Re: OTC Expert & Grey Market Restrictions
in response to
by
posted on
Nov 22, 2022 04:05PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
I have been unable to transact Zenith in my CIBC self directed investor's edge account other than by phone through a trader for over a year. It was considered an expert trade. Minimum cost per trade of $50 no matter how many shares I wanted to buy or sell. And no ability to keep the order open until I get a total fill. It's $50 per day whether I ended up with one share or 100,000.